Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 21, 2016

View Archived Issues

New phase I trial explores use of WOKVAC vaccine to prevent breast cancer recurrence

NIH award supports pancreatic cancer study of CivaSheet

Zydus Cadila and Takeda Pharmaceutical partner to tackle chikungunya

NCI awards contract to BioMarker Strategies for predictive test in NSCLC

ResistancePlus MG assay awarded CE-IVD mark

U.S. phase I study of oral OTS-167 to begin in breast cancer

Adgero Biopharmaceuticals obtains financing to support development of REM-001

MabVax Therapeutics gives update on phase I study of MVT-5873

Prozymex patents DPPI inhibitors

Teva and Regeneron enter global collaboration to develop and commercialize fasinumab

Asthma exacerbation model mimics the effects of viral respiratory infections

Amgen's phase III GLAGOV study of evolocumab meets endpoints

Sunovion Pharmaceuticals reports results from pivotal trial of dasotraline in ADHD

BioLineRx begins phase IIa study of BL-8040 plus pembrolizumab in pancreatic cancer

Danish scientists disclose DNA gyrase and topoisomerase IV inhibitors

EMA validates BMS' application to extend Opdivo indications

Long-acting growth hormone CJ-40002 is safe and effective in phase I trial

Amgen describes Nav1.7 channel blockers

Mirna Therapeutics stops phase I trial of MRX-34 following immune-related severe adverse events

BioNTech and Genentech to develop individualized mRNA-based cancer vaccines

Allergan to acquire Tobira Therapeutics

FDA grants fast track designation to Viaskin Milk

Phase III study of vepoloxamer in sickle cell disease does not meet primary efficacy endpoint

Bionomics reports promising phase II results for BNC-210 in generalized anxiety disorder

Kite Pharma signs license with NIH to target KRAS driven cancers

Serum NFL shows promise as a biomarker in RRMS

FDA grants orphan drug designation to CC-122

Follistatin gene therapy receives FDA orphan designation for inclusion body myositis

New biomarkers could help differentiate CIS patients from other forms of multiple sclerosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...